Clinical Trials Browser

OTHER × Lymphoma, B-Cell × Dexamethasone × Clear all

Burkitt Lymphoma, Lymphoma, B-Cell

NCT05476770 2024-12-06

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Hodgkin Disease, Leukemia, Biphenotypic, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02741388 2021-12-07

SELINDA

Phase 1 Completed

39 enrolled

Lymphoid

Lymphoma, Lymphoma, B-Cell

NCT00413959 2018-09-19

VRCD

Phase 2 Terminated

12 enrolled 7 charts

Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT02983097 2018-01-19

R²-DHAP

Phase 1/2 Terminated

34 enrolled

Lymphoid

Burkitt Lymphoma, Lymphoma, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Clinical Trials

Venetoclax Plus Inotuzumab for B-ALL

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

SELINDA

VRCD

R²-DHAP